Nucleolin was found to be overexpressed in several types of tumors such as melanoma [140], leukemia [141], gastric cancer [142], glioma [143], colorectal cancer [144], hepatocellular carcinoma [12], ependymoma [145], lung cancer [13] and breast cancer [146]. This evidence concerns the gene NUCLEOLIN and central nervous system cancer.